PMID: 42455418

Incretin-Based Therapies in Doxorubicin-Induced Cardiotoxicity: A Systematic Review of GLP-1 and Dual GIP/GLP-1 Agonists.

Khatami Seyedhesamoddin, Faghihi Mohammadsadegh, Tavakoli Ghazal, Szmit Sebastian, Yousefifard Mahmoud

Cardiovascular toxicology · 2026

Vol. 26, Issue 7

View on PubMedDOI

This entry links to third-party literature. For research use only.

AnimalsCardiotoxicityIncretinsDoxorubicinHumansHeart DiseasesGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide-1 ReceptorGastric Inhibitory PolypeptideSemaglutide

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.